| In Rs. Cr. | 202103 | 202203 | 202303 | 202403 | 202503 |
|---|---|---|---|---|---|
| Cash from Operating Activity+ | - | - | -305.98 | -294.55 | 298.65 |
| Cash from Investing Activity | - | - | 36.33 | -2806.31 | -1529.77 |
| Cash from Financing Activity | - | - | 308.20 | 4784.70 | -124.89 |
| Net Cash Flow | - | - | 38.55 | 1683.84 | -1356.01 |
| Opening Cash & Cash Equivalents | - | - | 160.76 | 199.31 | 1883.15 |
| Closing Cash & Cash Equivalents | - | - | 199.31 | 1883.15 | 527.14 |
| In Rs. Cr. | 202103 | 202203 | 202303 | 202403 | 202503 |
|---|---|---|---|---|---|
| Assets+ | - | - | 1902.92 | 7069.96 | 7942.79 |
| Liabilities+ | - | - | 1902.92 | 7069.96 | 7942.79 |
| In Rs. Cr. | 2023-03 | 2023-06 | 2024-03 | 2024-06 |
|---|---|---|---|---|
| Net Sales | 6.22 | 0.00 | 10.20 | 5.20 |
| Expenditure+ | 6.01 | 0.00 | 10.21 | 5.02 |
| Other Income+ | 0.06 | 0.00 | 0.31 | 0.57 |
| Operating Profit | 0.21 | 0.00 | -0.01 | 0.18 |
| Interest | 0.06 | 0.00 | 0.16 | 0.10 |
| Depreciation and Amortization | 0.01 | 0.00 | 0.03 | 0.16 |
| Profit Before Tax | 0.20 | 0.00 | 0.11 | 0.49 |
| Tax+ | -0.84 | 0.00 | 0.38 | 0.20 |
| Net Profit | 1.05 | 0.00 | -0.27 | 0.29 |
| In % | DEC'25 | SEP'25 | JUN'25 | MAR'25 | DEC'24 | SEP'24 | JUN'24 | MAR'24 | DEC'23 | SEP'23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoters+ | 29.98 | 29.98 | 29.98 | 29.98 | 29.98 | 29.98 | 29.98 | 29.98 | 59.96 | 59.96 |
| Public+ | 70.02 | 70.02 | 70.02 | 70.02 | 70.02 | 70.02 | 70.02 | 70.02 | 40.04 | 40.04 |
| Custodians | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Number of Shareholders | 104021 | 105804 | 107602 | 109080 | 109206 | 105838 | 108220 | 108137 | 89438 | 54458 |
₹1.2
- 0.05 (-4.00%)
04:01 pm - close price
BSE: GENPHARMA
NSE:
Industry: Trading
House: Private